Inmates in U.S. correctional facilities are approximately 9 times more likely to have hepatitis C virus (HCV) infection than the nonincarcerated population. Some correctional facilities provide HCV services, yet little is known about inmate and staff satisfaction with them. Using qualitative data collected in a prison-based drug treatment program in California, this paper describes inmate and staff perceptions of the benefits and barriers to delivering HCV services. Participants commented primarily on their peer education program and on perceived budgetary constraints as a barrier to ongoing HCV service delivery. Participants’ recommendations for the future included increasing HCV education and staff training, and expanding the peer educators program.
Get full access to this article
View all access options for this article.
References
1.
Allen, S. A. (2003). Developing a systematic approach to hepatitis C for correctional systems: Controversies and emerging consensus. HEPP Report, 6(4), 1-4. Available at http://www.hivcorrections.org
2.
Allen, S. A., Spaulding, A. C., Osei, A. M., Taylor, L. E., Cabral, A. M., & Rich, J. D. (2003). Treatment of chronic hepatitis C in a state correctional facility. Annals of Internal Medicine, 138(3), 187-190.
3.
Alter, M. J., Kruszon-MoranD., Nainan O. V., McQuillan, G. M., GaoF., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988-1994. New England Journal of Medicine, 341(8), 556-562.
4.
Alter M. J., & Moyer, L. A. (1998). The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(Suppl. 1), S6-10.
5.
Association of State and Territorial Health Officials. (2000, November). Hepatitis C & incarcerated populations: The next wave for correctional health initiatives. Washington, DC: Author. Retrieved February 18, 2004, from http://www.astho.org/pubs/HepC-Incarcerated.pdf
6.
BoudinK., CarreroI., ClarkJ., FlourneyV., LoftinK., MartindaleS., et al. (1999). ACE: A peer education and counseling program meets the needs of incarcerated women with HIV/AIDS issues. Journal of the Association of Nurses in AIDS Care, 10(6), 90-98.
7.
Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR-19), 1-39.
8.
Centers for Disease Control and Prevention. (2001, August). Drug use, HIV, and the criminal justice system. Retrieved January 3, 2003, from http://www.thebody.com/cdc/drug-use.html
Centers for Disease Control and Prevention. (2003a). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 52(RR-1), 1-35.
DeGroot, A. S., & BickJ. (2000). The correctional doctor’s dilemma: Hepatitis C treatment. HEPP News, 3(6), 1-6. Available at http://www.hivcorrections.org
13.
Durose, M. R., & Langan, P. A. (2003). Felony sentences in state courts, 2000 (Bureau of Justice Statistics Bulletin, NCJ 198821). Washington, DC: U.S. Department of Justice, Office of Justice Programs.
14.
Edlin, B. R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36(5), Suppl. 1, S210-S219.
15.
Fielding, J. E., & Kelch, D. R. (1998, February). Hepatitis C: A silent, deadly health threat: Data, education, research needed. Health Watch: Focus on Prevention, 1-4. Sacramento, CA: California Center for Health Improvement.
16.
Fox, R. K., CurrieS., Wright, T. L., ToblerL., DaileyP., PhelpsB., et al. (2002). Prevalence of hepatitis C in a sample of California prison inmates [Abstract]. Journal of General Internal Medicine, 17(Suppl. 1), 111-111.
17.
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & VlahovD. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(Suppl. 1), S11-S19.
18.
GrinsteadO., FaigelesB., & ZackB. (1997). The effectiveness of peer HIV education for male inmates entering state prison. Journal of Health Education, 28(6), November/December Suppl., S31-S37.
19.
Grinstead, O. A., ZackB., & FaigelesB. (1999). Collaborative research to prevent HIV among male prison inmates and their female partners. Health Education and Behavior, 26(2), 225-238.
20.
HaganH., McGough, J. P., ThiedeH., Weiss, N. S., HopkinsS., & Alexander, E. R. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology, 149(3), 203-213.
21.
HaganH., ThiedeH., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91(1), 42-46.
22.
Half a million Californians in jeopardy: Hearing on hep C reveals California is unprepared for latest public health epidemic. (1999, November 12). PR Newswire. Retrieved January 20, 2004, from http://www.aegis.com/news/pr/1999/PR991107.html
23.
Hammett, T. M. (2003). Adopting more systematic approaches to hepatitis C treatment in correctional facilities. Annals of Internal Medicine, 138(3), 235-236.
24.
Hammett, T. M., Gaiter, J. L., & CrawfordC. (1998). Reaching seriously at-risk populations: Health interventions in criminal justice settings. Health Education and Behavior, 25(1), 99-120.
25.
Hammett, T. M., HarmonP., & Maruschak, L. M. (1999). 1996- 1997 update: HI V/AIDS, STDs, and TB in correctional facilities (NCJ 176344). Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics.
26.
Hammett, T. M., Harmon, M. P., & RhodesW. (2002). The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. American Journal of Public Health, 92(11), 1789-1794.
27.
Liang, T. J., RehermannB., Seeff, L. B., & Hoofnagle, J. H. (2000). Pathogenisis, natural history, treatment, and prevention of hepatitis C. Annals of Internal Medicine, 132(4), 296-305.
28.
MahonN. (1996). New York inmates’ HIV risk behaviors: The implications for prevention policy and programs. American Journal of Public Health, 86(9), 1211-1215.
29.
National Commission on Correctional Health Care. (1999, November). The management of hepatitis C in correctional institutions. Chicago: Author. Retrieved February 19, 2004, from http://www.ncchc.org/resources/statements/hepc.html
Rich, J. D., HolmesL., SalasC., MacalinoG., DavisD., RyczekJ., et al. (2001). Successful linkage of medical care and community services for HIV-positive offenders being released from prison. Journal of Urban Health, 78, 279-289.
32.
Ruiz, J. D., MolitorF., & Plagenhoef, J. A. (2002). Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS, 16(16), 2236-2238.
33.
SpauldingA., GreeneC., DavidsonK., ShneidermannM., & RichJ. (1999). Hepatitis C in state correctional facilities. Preventive Medicine, 28(1), 92-100.
34.
University of California San Francisco. (2000, August). What is the role of prisons in HIV, hepatitis, STD and TB prevention? (Fact Sheet no. l3ER). San Francisco: UCSF Center for AIDS Prevention Studies. Available at http://www.caps.ucsf.edu/inmaterev.html
